More Business Wire
View Older Stories View Newer Stories-
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris
-
Thryv Achieves SaaS Revenue Growth of 34% in Full Year 2025, Shifts Focus to AI-Enabled "Market, Sell, Grow" Platform to Empower SMBs
-
Spanish Mountain Gold Drilling Intersects 205.87 Metres Grading 0.58 G/T Gold, 142.00 Metres of 0.77 G/T Gold, and 69.40 Metres of 0.99 G/T Gold in Three Separate Drill Holes Containing Numberous High
-
Cheniere Reports Fourth Quarter and Full Year 2025 Results, Introduces Full Year 2026 Financial Guidance, and Announces Completion of ‘20/20 Vision’ Capital Allocation Plan and New Share Repurchas
-
Ranpak to Hold Conference Call to Discuss Fourth Quarter 2025 Results
-
Cheniere Partners Reports Fourth Quarter and Full Year 2025 Results and Introduces Full Year 2026 Distribution Guidance
-
ImmunityBio Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA® Plus BCG Versus BCG Alone in BCG-Naïve Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
-
Cass Information Systems and Caspian Partner to Deliver Comprehensive Tariff Cost Management Solution
-
Telekom Srbija Group Secures Landmark International Credit Ratings from Fitch and Moody’s, Marking Historic First for Western Balkans
-
Blackline Safety Announces Fiscal First Quarter 2026 Financial Results Conference Call
-
Nuveen Churchill Direct Lending Corp. Announces Fourth Quarter 2025 Results
-
Cheniere and CPC Sign Long-Term LNG Sale and Purchase Agreement
-
Victory Capital Affirms Fully Financed, Clearly Superior Proposal to Acquire Janus Henderson
-
PNCC Selects LotusFlare to Power Digital BSS and Commerce Platform for New 4G/5G Standalone Network
-
Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction
-
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
-
Matt O’Hayer Retires from Vital Farms Board of Directors; President and CEO Russell Diez-Canseco Named as Executive Chairperson; Denny Marie Post Continues as Lead Independent Director
-
Fund Accountants Embrace AI as Integration Gaps and Manual Data Entry Persist, 2026 Research From Dynamo Software Shows
-
Munchkin Launches Infant Formula
-
Hilton Grand Vacations Reports Fourth Quarter and Full Year 2025 Results
-
Bentley Systems Announces Fourth Quarter and Full Year 2025 Results and 2026 Financial Outlook
-
The Middleby Corporation Reports Fourth Quarter and Fiscal Year Results
-
PENN Entertainment, Inc. Reports Fourth Quarter Results
-
Nexstar Media Group Reports Fourth Quarter Net Revenue of $1.29 Billion
-
BETA Technologies to Participate in Upcoming Investor Conferences
-
Frontdoor Announces Record Full-Year 2025 Financial Results
-
Vital Farms Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
-
Amazfit Introduces the Active 3 Premium: Turning Daily Movement into Meaningful Progress for Entry-Level Runners
-
IonQ Delivers One of the Largest Operational Quantum Key Distribution Networks in Europe
-
Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome
-
Silver Storm Reports 50% Completion of Processing Plant Rehabilitation Activities at La Parrilla
-
GoldState Music and Bridgepoint Announce Strategic Partnership Targeting Growth Investments
-
Shift4 Announces Fourth Quarter 2025 Results
-
Virtus Investment Partners Declares Quarterly Cash Dividend on Common Stock
-
D-Wave Reports Fourth Quarter and Year-End 2025 Results
-
Papa Johns Announces Fourth Quarter and Full Year 2025 Financial Results
-
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
-
Shake Shack Announces Fourth Quarter and Fiscal Year 2025 Financial Results
-
Upbound Group, Inc. to Participate in the 2026 Raymond James Institutional Investors Conference
-
BlackSky Reports Fourth Quarter and Full Year 2025 Results
-
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
-
Olezarsen sNDA accepted by the FDA for Priority Review for the treatment of severe hypertriglyceridemia (sHTG)
-
After a Breakout Year, SilverChef USA Ramps up Nationwide Expansion to Bring Flexible Financing to More Hospitality Operators
-
Palmer Square Capital BDC Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
-
Varicent Appoints Former Workday Co-President Doug Robinson to Board as It Redefines How Revenue Teams Operate At Scale
-
Alterome Therapeutics to Participate in Upcoming Investor Conferences
-
TIC Solutions Confirms Date for Fourth Quarter and Full Year 2025 Earnings Release and Announces Participation in Upcoming Investor Conferences
-
Cotality Appoints Former USAA CEO Wayne Peacock to Board
-
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple
